日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Assessing Cytochrome P450 Drug Interaction Risk for Dordaviprone Using Physiologically Based Pharmacokinetic Modeling

利用生理药代动力学模型评估多达维普隆与细胞色素P450药物相互作用的风险

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.70093
Jaiswal, Swati; Patel, Nikunjkumar K; Jones, Hannah M; McFeely, Savannah; Faison, Shamia L; Tippin, Tim; Naderer, Odin
细胞生物学
发表日期：2025
文献求助 收藏

Effect of Severe Renal Impairment on Dordaviprone (ONC201) Pharmacokinetics

严重肾功能损害对多达韦隆（ONC201）药代动力学的影响

期刊:Drugs in Research & Development
影响因子:2.1
doi:10.1007/s40268-025-00520-x
Faison, Shamia L; Batonga, Joelle; Arumugham, Thangam; Bartkus, Angela; Morrison, Marion E; Mullin, Mark J; Tippin, Tim; Naderer, Odin
发表日期：2025
文献求助 收藏

A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of Dordaviprone and the Effects of Food on the Bioavailability of Dordaviprone in Healthy Adult Subjects

一项评估多达维普隆单次递增口服剂量安全性、耐受性和药代动力学以及食物对健康成年受试者多达维普隆生物利用度影响的 1 期随机研究

期刊:Clinical Pharmacology in Drug Development
影响因子:1.8
doi:10.1002/cpdd.1512
Faison, Shamia L; Batonga, Joelle; Arumugham, Thangam; Bartkus, Angela; Morrison, Marion; Mullin, Mark J; Tippin, Tim; Naderer, Odin
发表日期：2025
文献求助 收藏

Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma

在患有 H3 K27M 突变型胶质瘤的儿科患者中，每周连续两天服用 ONC201（多达韦普隆）的安全性和药代动力学研究

期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noae001
Odia, Yazmin; Koschmann, Carl; Vitanza, Nicholas A; de Blank, Peter; Aguilera, Dolly; Allen, Jeffrey; Daghistani, Doured; Hall, Matthew; Khatib, Ziad; Kline, Cassie; MacDonald, Tobey; Mueller, Sabine; Faison, Shamia L; Allen, Joshua E; Naderer, Odin J; Ramage, Samuel C; Tarapore, Rohinton S; McGovern, Susan Lynne; Khatua, Soumen; Zaky, Wafik; Gardner, Sharon L
胶质瘤
发表日期：2024
文献求助 收藏

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults

健康成人同时服用维洛沙嗪缓释片（SPN-812）和赖右苯丙胺的药代动力学研究

期刊:Journal of Clinical Psychopharmacology
影响因子:2.8
doi:10.1097/JCP.0000000000001361
Faison, Shamia L; Fry, Nicholas; Adewole, Toyin; Odebo, Oyinkansola; Wang, Zhao; Maletic, Vladimir; Nasser, Azmi
SPN
发表日期：2021
文献求助 收藏

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults

健康成人同时服用维洛沙嗪缓释片（SPN-812）和哌甲酯的药代动力学研究

期刊:Clinical Drug Investigation
影响因子:2.7
doi:10.1007/s40261-020-00992-6
Faison, Shamia L; Fry, Nicholas; Adewole, Toyin; Odebo, Oyinkansola; Schwabe, Stefan; Wang, Zhao; Maletic, Vladimir; Nasser, Azmi
SPN
发表日期：2021
文献求助 收藏

l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats

l-四氢巴马汀可降低大鼠尼古丁的自我给药和恢复

期刊:BMC Pharmacology & Toxicology
影响因子:2.8
doi:10.1186/s40360-016-0093-6
Shamia L Faison, Charles W Schindler, Steven R Goldberg, Jia Bei Wang
信号转导
发表日期：2016
文献求助 收藏